A Safety, Tolerability, Efficacy and QoL Study of Human recAP in the Treatment of Patients With SA-AKI

Name: A Safety, Tolerability, Efficacy and QoL Study of Human recAP in the Treatment of Patients With SA-AKI
Published: 2014
License: Public Domain

AM-Pharma · 2014

ClinicalTrials.gov · Datasets · License: Public Domain · 2014

Open Source ↗

acute-kidney-injury sepsis

acute kidney injury, sa-aki, sepsis, aki, recombinant alkaline phosphatase, recap, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Safety, Tolerability, Efficacy and QoL Study of Human recAP in the Treatment of Patients With SA-AKI

Related documents